East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro Labs

East Ocyon Bio, an allogeneic Cell & Gene Therapy (CGT) startup, on Wednesday, announced the closure of its $4.2 million seed round. The investment round was led by Aeravti Ventures and Micro Labs. The newly raised funds will be utilised to enable several initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell therapies, the creation of a GMP manufacturing facility, and Phase I clinical trials.Renu Kundu, Founder of East Ocyon Bio, said in a statement, “We are incredibly grateful for the support of Aeravti Ventures and Micro Labs,…